Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.21/3848
Título: Delivering a disease-modifying treatment for Huntington’s disease
Autor: Godinho, Bruno M. C.
Malhotra, Meenakshi
O’Driscoll, Caitriona M.
Cryan, John F.
Palavras-chave: Huntington's disease
Neurodegenerative disorder
Huntingtin gene
RNA interference
DNA enzymes
Data: Jan-2015
Editora: Elsevier
Citação: Godinho BM, Malhotra M, O’Driscoll CM, Cryan JF. Delivering a disease-modifying treatment for Huntington’s disease. Drug Discov Today. 2015;20(1):50-64.
Resumo: Huntington's disease (HD) is an incurable genetic neurodegenerative disorder that leads to motor and cognitive decline. It is caused by an expanded polyglutamine tract within the Huntingtin (HTT) gene, which translates into a toxic mutant HTT protein. Although no cure has yet been discovered, novel therapeutic strategies, such as RNA interference (RNAi), antisense oligonucleotides (ASO), ribozymes, DNA enzymes, and genome-editing approaches, aimed at silencing or repairing the mutant HTT gene hold great promise. Indeed, several preclinical studies have demonstrated the utility of such strategies to improve HD neuropathology and symptoms. In this review, we critically summarise the main advances and limitations of each gene-silencing technology as an effective therapeutic tool for the treatment of HD.
Peer review: yes
URI: http://hdl.handle.net/10400.21/3848
DOI: 10.1016/j.drudis.2014.09.011
Versão do Editor: http://www.sciencedirect.com/science/article/pii/S1359644614003778#
Aparece nas colecções:ESTeSL - Artigos

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.